Concepedia

Author

Daniel Corum

Medical University of South Carolina

Also Known As

D G Corum, D. Corum, Daniel Corum, Daniel G. Corum, Maël Heiblig

35

Publications

1.1K

Citations

13

H-Index

56

Concepts

All Affiliations

Medical University of South CarolinaKura Oncology (United States)Roswell Park Comprehensive Cancer CenterNorthwestern UniversityDuke University
DC

About

Daniel Corum is an author at Medical University of South Carolina specializing in medicine, cell biology, and genetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

511

2

Engineering

1

1

311

3

Natural Sciences

1

1

14

4

Public Health

1

1

128

5

Biochemistry

1

1

16

Daniel Corum

×

12

Publications

799

Citations

12

H-Index

YearCitations

Zebrafish developmental screening of the ToxCast™ Phase I chemical library

Stephanie Padilla, Daniel Corum, Beth Padnos,

Reproductive Toxicology

2011

311

Profiling the Reproductive Toxicity of Chemicals from Multigeneration Studies in the Toxicity Reference Database

Matthew T. Martin, Elizabeth Méndez, Daniel Corum,

Toxicological Sciences

2009

128

Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants

Daniel M. Rotroff, Daniel Corum, Alison A. Motsinger‐Reif,

Translational Psychiatry

2016

97

Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β <sub>2</sub> -Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury

Natalie E. Scholpa, Hannah C. Williams, Wenxue Wang,

Journal of Neurotrauma

2018

53

5‐HT<sub>1F</sub> receptor‐mediated mitochondrial biogenesis for the treatment of Parkinson's disease

Natalie E. Scholpa, Mary K. Lynn, Daniel Corum,

British Journal of Pharmacology

2017

46

AKT3 controls mitochondrial biogenesis and autophagy <i>via</i> regulation of the major nuclear export protein CRM‐1

Daniel Corum, Philip N. Tsichlis, Robin C. Muise‐Helmericks

The FASEB Journal

2013

42

Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans

Daniel M. Rotroff, Noffisat O. Oki, Xiaomin Liang,

Frontiers in Pharmacology

2016

37

Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed <i>NPM1-</i>m or <i>KMT2A</i>-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007

Amer M. Zeidan, Eunice S. Wang, Ghayas C. Issa,

Blood

2024

24

Ziftomenib Combined with Venetoclax/Azacitidine in Relapsed/Refractory <i>NPM1</i>-m or <i>KMT2A</i>-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007

Amir T. Fathi, Ghayas C. Issa, Eunice S. Wang,

Blood

2024

18

PDE5 inhibition rescues mitochondrial dysfunction and angiogenic responses induced by Akt3 inhibition by promotion of PRC expression

Daniel Corum, Dorea P. Jenkins, James A. Heslop,

Journal of Biological Chemistry

2020

16

Page 1